HCMV chronic infection leads to marked changes in the immune system [7], mainly characterized by the differentiation and expansion of specific T cells [8] and adaptive NK cell subsets expressing the CD94/NKG2C activating receptor [9], a phenotypic feature that has been associated with reduced MS progression [10]. This evidence concerns the gene KLRC2 and myeloid sarcoma.